Prospect of a Nanotherapy Based Cure for Liver Fibrosis 💊🦠🧪
Liver cirrhosis, which starts as liver fibrosis (scarring) is a considerable cause of morbidity and death worldwide. Without any licensed antifibrotic therapies and availability of liver transplants being limited, it usually leads to death. However, due to recent developments in biotechnology and medicine, there has been an increasing prospect in the use of naturally occurring peptide hormone human-relaxin 2 (RLX) as a possible therapeutic agent. RLX is vasodilatory, promotes tissue remodeling and is anti-fibrotic across major organs.